The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NU HLDGS LTD ORD SHS CL A G6683N103   17,083,175 1,431,951 SH   SOLE   1,431,951 0 0
AKERO THERAPEUTICS INC COM 00973Y108   9,411,245 372,575 SH   SOLE   372,575 0 0
89BIO INC COM 282559103   5,798,315 498,137 SH   SOLE   498,137 0 0
GENERAL ELECTRIC CO COM NEW 369604301   12,126,139 69,083 SH   SOLE   69,083 0 0
ISHARES TR CORE S&P500 ETF 464287200   29,148,048 55,443 SH   SOLE   55,443 0 0
MADRIGAL PHARMACEUTICALS INC COM 558868105   15,054,647 56,376 SH   SOLE   56,376 0 0